Arnett Lab

Dr. Arnett and her research team aim to improve precision medicine care for children and families affected by neurodevelopmental disorders. Dr. Arnett’s laboratory investigates brain-behavior associations leading to atypical neurodevelopment among children. Research initiatives have included investigations of neurocognitive and genetic etiologies of ADHD, learning disorders and autism; as well as single gene disorders associated with autism and intellectual disability.

A more detailed breakdown of the Arnett Lab research goals:Brain graphic

  1. School-aged children with ADHD and related neurodevelopmental disorders: What cognitive, neuropsychological, and genetic factors are associated with diagnoses of attention deficit hyperactivity disorder (ADHD) and associated symptoms?
  2. Preschool-aged children at risk for ADHD: Are there neurocognitive differences that we can measure using EEG and neuropsychological testing that will predict which children at risk for ADHD will go on to develop the disorder in later childhood?
  3. Brain-based biomarkers associated with neurodevelopmental disorders: What can neurobiological markers of ADHD and neurodevelopmental disorders tell us about the origin of these symptoms? How can these biomarkers help us develop individualized treatment plans for each child and family?

Interested in Participating in Research at Boston Children's Hospital?

Please fill out the form below to have your family added to our Research Participant Registry. We will contact you if there is a study we think you might be eligible for. By signing up, you are not agreeing to participate; you are just agreeing to be contacted with more information.

 

If you are interested in participating in the Arnett Lab studies in particular, you may email ArnettLab@childrens.harvard.edu. We look forward to hearing from you!